NORFLEX Drug Patent Profile
✉ Email this page to a colleague
When do Norflex patents expire, and when can generic versions of Norflex launch?
Norflex is a drug marketed by Pai Holdings Pharm and Bausch and is included in two NDAs.
The generic ingredient in NORFLEX is orphenadrine citrate. There are nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the orphenadrine citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norflex
A generic version of NORFLEX was approved as orphenadrine citrate by WATSON LABS on March 15th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORFLEX?
- What are the global sales for NORFLEX?
- What is Average Wholesale Price for NORFLEX?
Summary for NORFLEX
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Clinical Trials: | 3 |
| Patent Applications: | 869 |
| DailyMed Link: | NORFLEX at DailyMed |
Recent Clinical Trials for NORFLEX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Illinois College of Medicine at Peoria | Phase 4 |
| OSF Healthcare System | Phase 4 |
| Florida Hospital | Phase 4 |
US Patents and Regulatory Information for NORFLEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pai Holdings Pharm | NORFLEX | orphenadrine citrate | INJECTABLE;INJECTION | 013055-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch | NORFLEX | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 012157-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
